STP-206 / Leadiant Biosci - LARVOL DELTA

STP206 for the Prevention of NEC (clinicaltrials.gov) - P1; N=103; Completed; Sponsor: Leadiant Biosciences, Inc.; Recruiting ➔ Completed; Phase classification: P1/2 ➔ P1; N=400 ➔ 103; Trial completion date: Dec 2019 ➔ Sep 2018

Clinical • Enrollment change • Phase classification • Trial completion • Trial completion date